QUEBEC CITY, March 21, 2013 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (AEZ.TO) (the "Company"), a late-stage drug development company specializing in oncology and endocrinology, today reported financial and operating results as at and for the fourth quarter and the year ended December 31, 2012 .
